IPSC
Price
$1.70
Change
+$0.03 (+1.80%)
Updated
Feb 6 closing price
Capitalization
150.34M
32 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$21.03
Change
+$1.00 (+4.99%)
Updated
Feb 6 closing price
Capitalization
2.6B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IPSC vs RCUS

Header iconIPSC vs RCUS Comparison
Open Charts IPSC vs RCUSBanner chart's image
Century Therapeutics
Price$1.70
Change+$0.03 (+1.80%)
Volume$1.57M
Capitalization150.34M
Arcus Biosciences
Price$21.03
Change+$1.00 (+4.99%)
Volume$833.11K
Capitalization2.6B
IPSC vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
IPSC vs. RCUS commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (IPSC: $1.70 vs. RCUS: $21.03)
Brand notoriety: IPSC and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 75% vs. RCUS: 51%
Market capitalization -- IPSC: $150.34M vs. RCUS: $2.6B
IPSC [@Biotechnology] is valued at $150.34M. RCUS’s [@Biotechnology] market capitalization is $2.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, IPSC is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • IPSC’s TA Score: 3 bullish, 5 bearish.
  • RCUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both IPSC and RCUS are a bad buy in the short-term.

Price Growth

IPSC (@Biotechnology) experienced а -10.53% price change this week, while RCUS (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

IPSC is expected to report earnings on Mar 12, 2026.

RCUS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($2.6B) has a higher market cap than IPSC($150M). IPSC YTD gains are higher at: 70.889 vs. RCUS (-11.750). IPSC has higher annual earnings (EBITDA): -909K vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. IPSC (133M). IPSC has less debt than RCUS: IPSC (45M) vs RCUS (111M). RCUS has higher revenues than IPSC: RCUS (240M) vs IPSC (113M).
IPSCRCUSIPSC / RCUS
Capitalization150M2.6B6%
EBITDA-909K-323M0%
Gain YTD70.889-11.750-603%
P/E RatioN/AN/A-
Revenue113M240M47%
Total Cash133M831M16%
Total Debt45M111M41%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPSCRCUS
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICAGY11.950.61
+5.38%
International Consolidated Airlines Group SA
ENTEF0.04N/A
+3.90%
ESE Entertainment Inc.
GLAPY99.00N/A
N/A
Glanbia Plc
RCKHF0.98N/A
N/A
Rockhopper Exploration Plc
GLFGF0.33N/A
N/A
GLOBAL FASHION GROUP SA

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been closely correlated with ACET. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if IPSC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+1.80%
ACET - IPSC
88%
Closely correlated
+9.16%
ATOS - IPSC
86%
Closely correlated
+0.19%
TERN - IPSC
85%
Closely correlated
+6.88%
STRO - IPSC
85%
Closely correlated
+6.30%
ERAS - IPSC
85%
Closely correlated
+3.45%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with TRDA. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+4.99%
TRDA - RCUS
66%
Loosely correlated
+5.26%
IMNM - RCUS
65%
Loosely correlated
+3.67%
SYRE - RCUS
63%
Loosely correlated
+6.62%
IPSC - RCUS
62%
Loosely correlated
+1.80%
COGT - RCUS
62%
Loosely correlated
+3.87%
More